Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merve Denizli

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Lymphatic Research and Biology|April 18, 2019
LIMPRINT Study: The Turkish ExperiencePinar Borman, Christine Moffatt, Susie Murray, et al.
Oncotarget|April 21, 2017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsMohammed H Rashed, Pinar Kanlikilicer, Cristian Rodriguez-Aguayo, et al.
Ebiomedicine|January 24, 2020
Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Ebiomedicine|December 5, 2024
Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Lymphatic Research and Biology|April 18, 2019
LIMPRINT Study: The Turkish ExperiencePinar Borman, Christine Moffatt, Susie Murray, et al.
Oncotarget|April 21, 2017
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAsMohammed H Rashed, Pinar Kanlikilicer, Cristian Rodriguez-Aguayo, et al.
Ebiomedicine|January 24, 2020
Corrigendum to 'Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer' [EBioMedicine 38 (2018) 100-112]Pinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Ebiomedicine|December 5, 2024
Corrigendum to Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer ModelsPinar Kanlikilicer, Bulent Ozpolat, Burcu Aslan, et al.
Pageof 2